F-star Therapeutics, Inc. — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$21.2M

Net Income/Loss (FY2021)

-$31.3M

Total Assets (FY2021)

$123.0M

Total Equity (FY2021)

$96.9M

Cash Flows from Operating Activities (FY2021)

-$27.3M

Source: F-star Therapeutics, Inc. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.